The pathogenesis includes mutations in specific genes involved in the proper development of blood vessels, including endoglin (ENG), activin receptor-like kinase type 1 (ACVRL1), or SMAD4 genes, leading to HHT 1, HHT 2, and juvenile polyposis HHT, respectively. The gene discussed is ENG; the disease is hereditary hemorrhagic telangiectasia.